Ximelagatran was expected to replace warfarin and sometimes aspirin and heparin in many therapeutic settings, including deep venous thrombosis, prevention of secondary venous thromboembolism and complications of atrial fibrillation such as stroke. It is an anticoagulant. Reference standards of Ximelagatran API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => N-Boc-D-cyclohexylglycine-d11 [catalogue_number] => PA STI 013890 [category_ids] => ,97,69,70,98, [chemical_name] => [weight] => 268.39 [form] => C13H12D11NO4 [cas] => 1246820-33-6 [pslug] => 1246820-33-6-n-boc-d-cyclohexylglycine-d11-pasti013890 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA STI 013890
CAS :
Molecular Formula : C13H12D11NO4
Molecular Weight : 268.39
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
